← Leaderboards
Andrea Apolo
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseTransitional Cell CarcinomaTumorMalignant Neoplasm Of Urinary BladderPhase 2 StudyClinical TrialsMalignant NeoplasmsCohortBasePathway InteractionsDoseChemotherapyCisplatinUrineSignal TransductionMediator Of Activation ProteinVascular Endothelial Growth FactorsPharmaceutical PreparationsRadiologistCancer CellAnchorage-Independent GrowthDesignInhibitor/AntagonistPrograms
Grant awards (35)
Rare genitourinary tumors projects$1,193,036
ZIA · FY2025 · CA · contact PI
Bladder Cancer Program$1,060,475
ZIA · FY2025 · CA · contact PI
Targeting the MET Pathway in Urothelial Carcinoma$397,679
ZIA · FY2025 · CA · contact PI
Rare genitourinary tumors projects$1,339,880
ZIA · FY2024 · CA · contact PI
Bladder Cancer Program$1,191,004
ZIA · FY2024 · CA · contact PI
Targeting the MET Pathway in Urothelial Carcinoma$446,627
ZIA · FY2024 · CA · contact PI
Rare genitourinary tumors projects$978,735
ZIA · FY2023 · CA · contact PI
Bladder Cancer Program$869,986
ZIA · FY2023 · CA · contact PI
Targeting the MET Pathway in Urothelial Carcinoma$326,245
ZIA · FY2023 · CA · contact PI
Targeting the MET Pathway in Urothelial Carcinoma$1,189,328
ZIA · FY2022 · CA · contact PI
Bladder Cancer Program$1,057,180
ZIA · FY2022 · CA · contact PI
Rare genitourinary tumors projects$396,442
ZIA · FY2022 · CA · contact PI
Targeting the MET Pathway in Urothelial Carcinoma$771,530
ZIA · FY2021 · CA · contact PI
Bladder Cancer Program$685,804
ZIA · FY2021 · CA · contact PI
Rare GU tumors projects$257,177
ZIA · FY2021 · CA · contact PI
Targeting the MET Pathway in Urothelial Carcinoma$688,082
ZIA · FY2020 · CA · contact PI
Bladder Cancer Program$611,629
ZIA · FY2020 · CA · contact PI
Rare GU tumors projects$229,361
ZIA · FY2020 · CA · contact PI
Targeting the MET Pathway in Urothelial Carcinoma$704,862
ZIA · FY2019 · CA · contact PI
Bladder Cancer Program$626,544
ZIA · FY2019 · CA · contact PI
Rare GU tumors projects$234,954
ZIA · FY2019 · CA · contact PI
Targeting the MET pathway in urothelial carcinoma$701,587
ZIA · FY2018 · CA · contact PI
Bladder Cancer Program$467,725
ZIA · FY2018 · CA · contact PI
Targeting the MET pathway in urothelial carcinoma$746,951
ZIA · FY2017 · CA · contact PI
Bladder Cancer Program$497,967
ZIA · FY2017 · CA · contact PI
Targeting the MET pathway in urothelial carcinoma$786,431
ZIA · FY2016 · CA · contact PI
Bladder Cancer Program$524,287
ZIA · FY2016 · CA · contact PI
Targeting the MET pathway in urothelial carcinoma$777,916
ZIA · FY2015 · CA · contact PI
Bladder Cancer Program$518,611
ZIA · FY2015 · CA · contact PI
Targeting the MET pathway in urothelial carcinoma$380,551
ZIA · FY2014 · CA · contact PI
Bladder Cancer Program$253,700
ZIA · FY2014 · CA · contact PI
Bladder Cancer Program$381,261
ZIA · FY2013 · CA · contact PI
Bladder Cancer Program$201,384
ZIA · FY2012 · CA · contact PI
Bladder Cancer Program$206,261
ZIA · FY2011 · CA · contact PI
Bladder Cancer Program$211,946
ZIA · FY2010 · CA · contact PI